Funding, News and Announcements

The United States Department of Defense is offering four competitions through their ALS research program.  

Therapeutic Development Award:

• Supports secondary preclinical validation and IND-enabling studies of therapeutics for ALS.
• Valued at up to $1,000,000 USD over three years.

Therapeutic Idea Award:

• Supports hypothesis-driven preclinical therapeutic development.
• Early Career researchers are encouraged to apply.
• Valued at up to $600,000 USD over two years.

Clinical Development Award:

• Supports correlative clinical research and leveraging of human-based ALS resources.
• Valued at $500,000 USD over two years.

Therapeutic/Biomarker Pilot Trial Award:

• Supports exploratory clinical trials to demonstrate feasibility or inform the design of more advanced trials for the treatment or management of ALS.
• Valued at up to $2,000,000 over four years.

Full details available here. 

Deadlines

Internal: Five business days prior to funder deadline. Contact Erin Murphy erin.murphy@dal.ca

Funder: Pre-applications are due April 9, 2021. Contact Help@ebrap.org